Sign In
Buy SNY
$42.37
-0.430 (-1.00%)
At Close: Jun 03, 2026
Sanofi stops supply of high cholesterol drug to China due to limited availability
06:14am, Tuesday, 12'th Aug 2025
Sanofi said on Tuesday it had stopped supplying Praluent, a popular cholesterol drug jointly developed by the French pharmaceuticals firm and its partner Regeneron Pharmaceuticals, in China due to lim
Sanofi: Playing To Win
11:01am, Thursday, 07'th Aug 2025
Sanofi's strategic pivot to immunology and rare diseases, plus AI-driven R&D, targets higher margins and sustainable long-term growth. Blockbuster drugs like Dupixent, Altuviiio, and Beyfortus, alongs
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
01:00am, Wednesday, 06'th Aug 2025
Sanofi completes the acquisition of Vigil Neuroscience, Inc. Paris, August 6, 2025. Sanofi announces the completion of its acquisition of Vigil Neuroscience, Inc. (“Vigil”).
Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.
Arrowhead Subsidiary Visirna Sells Rights to Hypertriglyceridemia Candidate Plozasiran in Greater China to Sanofi
06:30am, Friday, 01'st Aug 2025
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the signing of an asset purchase agreement between Sanofi and Visirna Therapeutics, a majori
Sanofi (SNY) Q2 2025 Earnings Call Transcript
04:50pm, Thursday, 31'st Jul 2025
Sanofi (NASDAQ:SNY ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Brian Foard - Executive VP & Head of Specialty Care François-Xavier Roger - Executive VP & CFO Houm
Trump pressures 17 pharma CEOs to cut US drug prices
02:28pm, Thursday, 31'st Jul 2025
U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans, the White House sa
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
01:48pm, Thursday, 31'st Jul 2025
President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days. It comes after Trump in May signed an executive order reviving a cont
Press release: Online availability of Sanofi's half-year financial report for 2025
12:20pm, Thursday, 31'st Jul 2025
Online availability of Sanofi's half-year financial report for 2025 Paris, July 31, 2025. Sanofi announces that its half-year financial report for the period ending June 30, 2025 is now available and
Sanofi Q2 Earnings & Sales Miss, 2025 Top-Line View Raised, Stock Down
11:41am, Thursday, 31'st Jul 2025
SNY misses Q2 earnings and sales estimates but lifts 2025 sales outlook on strong Dupixent and vaccine momentum.
Sanofi's Q2 Earnings Fall Short On Expectations Despite 21% Jump In Dupixent Sales
10:10am, Thursday, 31'st Jul 2025
Sanofi SA SNY reported second-quarter sales of $11.33 billion (€9.99 billion euros), narrowly missing the consensus of $11.53 billion.
Sanofi CEO Paul Hudson on Q2 results, Dupixent demand and tariff impact
08:33am, Thursday, 31'st Jul 2025
Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, Blueprint acquisition, strong demand for Dupixent, drug pipeline outlook, impact of tariffs, and more.
Sanofi revises annual sales growth expectations on strong Dupixent demand
01:41am, Thursday, 31'st Jul 2025
France's Sanofi said on Thursday that it expects annual sales to grow by high single-digit percentage, helped by strong demand for its anti-inflammatory drug Dupixent, as well as vaccines and newer tr
Press Release: Sanofi's SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma
01:00am, Wednesday, 30'th Jul 2025
Sanofi's SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma Designation granted for IgG1-based GPRC5D monoclonal antibody for the potential treatment
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
01:42pm, Monday, 28'th Jul 2025
The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said
